Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes

Journal of Virology

Volumn 76, Issue 1, 2002, Pages 208-219

  Martin Serrano, J ^a   Li, K ^a   Bieniasz, P D ^a  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN T1; PHORBOL ESTER; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL IMMORTALIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; TRANSCRIPTION INITIATION; VIRUS LATENCY; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BINDING SITES; CELLS, CULTURED; CYCLINS; GENE PRODUCTS, TAT; HIV-1; HUMANS; JURKAT CELLS; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; U937 CELLS; UP-REGULATION; VIRUS LATENCY;

EID: 0036132835     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.1.208-219.2002     Document Type: Article

References (56)

1. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts
2. Canine cyclin T1 rescues equine infectious anemia virus tat trans-activation in human cells
3. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes
4. CpG islands as genomic footprints of promoters that are associated with replication origins
5. Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus
6. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: Regulatory role for the protooncogene ETS1
7. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes
8. Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism
9. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat
10. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription
11. Functional differences between human and bovine immunodeficiency virus Tat transcription factors
12. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection
13. The κB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth
14. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
15. Reversible phosphorylation of the C-terminal domain of RNA polymerase II
16. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation
17. HIV-1 tat trans-activation requires the loop sequence within tar
18. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
19. Relief of two built-in autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter
20. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription
21. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat
22. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T
23. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA
24. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein
25. Upregulation of cyclin T1/CDK9 complexes during T cell activation
26. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines
27. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions
28. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor
29. HIV promoter activity in primary antigen-specific human T lymphocytes
30. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation
31. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
32. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells
33. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation
34. Isolation and characterization of the human cyclin T1 promoter
35. The NF-kappa B independent cis-acting sequences in HIV-1 LTR responsive to T-cell activation
36. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo
37. HIV-1 Tat protein promotes formation of more-processive elongation complexes
38. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase
39. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
40. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: Effects on promoter activity
41. The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity
42. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription
43. Identification of multiple cyclin subunits of human P-TEFb
44. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II
45. Ets target genes: Past, present and future
46. The housekeeping promoter from the mouse CpG island HTF9 contains multiple protein-binding elements that are functionally redundant
47. HIV-1 replication is controlled at the level of T cell activation and proviral integration
48. Tat transactivation: A model for the regulation of eukaryotic transcriptional elongation
49. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence
50. FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH
51. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro
52. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
53. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b
54. HIV-1 latency due to the site of proviral integration
55. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation
56. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure